Issue 71 | June 2018
In this issue: A surge of M&A activity in the biotech space, the history of drug development for mumps, a profile of the Swiss pharmaceutical market, using digital tech to unlock billions in savings for pharma companies, and more.
Click to view.
Issue 70 | May 2018
In this issue: A toolkit to enhance the user experience for life sciences, the problem of unapproved antibiotics in India, a new taxonomy for traditional Chinese medicine, inside Canada’s Centre for Drug Research and Development, and more.
Click to view.
Issue 69 | April 2018
In this issue: The world’s pharma manufacturing hotspots, creating a universal flu vaccine, obstacles to improving the treatment of Alzheimer’s disease, the potential of growth drugs, detecting racemisation in drugs, and more.
Click to view.
Issue 68 | March 2018
In this issue: The benefits of seamless clinical trials, a new functional cure for HIV, using mRNA to target cancer tumours, the potential of magnetic hyperthermia in killing cancerous cells, a look at drug pricing policies around the world, and more.
Click to view.
Issue 67 | February 2018
In this issue: How cancer drug resistance works, accessing funding for rare diseases, India’s attempt to redefine over the counter drugs, the biotech potential of slipper limpets, Dundee University’s influence in pharma research, and more.
Click to view.
Issue 66 | January 2018
In this issue: Breaking cancer’s drug addiction, the NHS’ decision to switch from biologics to biosimilars, Elsevier’s common model for data sharing, a generic antiretroviral for HIV/AIDS, the opioid addiction crisis in the US, and more.
Click to view.
Special Issue | Yearbook 2017
In this issue: We round up the biggest pharma developments and stories from around the globe in 2017, consider the impact Brexit could have on IDMP preparations, take a closer look at the outlook for the pharmaceutical industry in 2018, and more.
Click to view.
Issue 65 | December 2017
In this issue: Calls for closer ties between the NHS and pharma, Norway’s unique prescription database, a new way to reduce the risk of heart attacks, MDMA’s potential to treat PTSD, a curative compound derived from red sage, and more.
Click to view.
Issue 64 | November 2017
In this issue: Using drugs after their expiration dates have passed, treating lactose intolerance, a closer look at CARB-X’s work on antibacterial research and development, helping nanomedicines reach their target, radioactive isotopes battling cancer, and more.
Click to view.
Issue 63 | October 2017
In this issue: UK pharma industry takes NICE to court over price caps, Amazon’s potential to enter the US pharmacy industry, a new platform to capture molecules from fungi, the current state of drug development in osteoporosis, and more.
Click to view.
Issue 62 | September 2017
In this issue: A new tool to encourage links between industry and academia, blockchain’s applications for pharma, using Zika to attack brain tumour cells, treating MS with nanotechnology, the benefits of publicly funded cancer trials, and more.
Click to view.
Issue 61 | August 2017
In this issue: The UK’s healthcare spending problem, PhRMA’s new R&D spending requirements, undermining supply chain security by importing foreign drugs, milestone cystic fibrosis trials, a personalised treatment approach for panic disorder, and more.
Click to view.
Issue 60 | July 2017
In this issue: Solving US drug pricing issues by importing cheaper Canadian drugs, underexplored fields in immuno-oncology, a new temperature-resistant rabies and yellow fever vaccine, the increasingly popularity of adaptive clinical trials, and more.
Click to view.
Issue 59 | June 2017
In this issue: Challenging the link between innovation and US drug pricing, the impact of Brexit on life sciences companies, a new study on the effects of cognitive-enhancing drugs, using crowdfunding to unlock cancer therapies, and more.
Click to view.
Issue 58 | May 2017
In this issue: Promising Alzheimer’s drugs in development, potential applications for the hormone kisspeptin, the cost of failed drug candidates, a new app matching patients to clinical trials, pharma packaging trends, and more.
Click to view.
Issue 57 | April 2017
In this issue: Japan’s pharma industry looks abroad, Trump’s plans for US drug manufacturing, unlocking regenerative medicine, the medical benefits of turmeric, the dangers posed by first-in-human drug trials, and more.
Click to view.
Issue 56 | March 2017
In this issue: Clinical research in the UK, fighting diabetes with peptides, balancing speed and safety when reviewing new drugs, the potential of shark antibodies to treat Alzheimer’s, Elsevier’s new project to boost innovation, and more.
Click to view.
Issue 55 | February 2017
In this issue: India’s new drug pricing policy, bringing transparency to pharma industry payments, a UK innovation centre enabling new means of drug discovery, how artificial intelligence is being used in drug development, and more.
Click to view.
Issue 54 | January 2017
In this issue: Senator Bernie Sanders continues to rail against the pharma industry, why companies pay to prolong patents, a new genomic array helping fight disease in Africa, treating mononucleosis, a new era for ibuprofen, and more.
Click to view.
Issue 53 | December 2016
In this issue: Pfizer’s acquisition of AstraZeneca’s antibiotics unit, new ideas to tackle antimicrobial resistance, vaccines to look out for in 2017, targeting Tourette syndrome, using ketamine to treat depression, and more.
Click to view.
Issue 52 | November 2016
In this issue: A report calls for Oxford and Cambridge to work together in the biopharma sector, IBM’s new lab-on-a-chip technology, whether harnessing telomerase could trick the ageing process, how BERG is using AI to develop drugs, and more.
Click to view.
Issue 51 | October 2016
In this issue: Efficiency in Australia’s pharma industry, India’s move to biosimilars, painkillers that don’t rely on opioids, NHS England’s funding of HIV drug PrEP, whether stem cell transplants can be used to treat MS, and more.
Click to view.
Issue 50 | September 2016
In this issue: Maximising investment by cancer megafunds, positive clinical trials for an antibody to treat lupus, how copper can be used to tackle obesity, whether day and night should influence our drug regimes, a device to soak up excess drugs and more.
Click to view.
Issue 49 | August 2016
In this issue: Improving treatment for refugees, making global drug price regulation work, a new approach to AMR, tackling depression with psilocybin, combating counterfeit Viagra, innovations in temperature controlled packaging and more.
Click to view.
Issue 48 | July 2016
In this issue: Nurturing an African pharma boom, the challenges of designing biodegradable drugs, the UK’s R&D tax credit scheme, advances in prostate cancer treatment, treating heroin addiction, best practice for anonymising clinical trial data and more.
Click to view.
Issue 47 | June 2016
In this issue: The breast cancer drug pipeline, getting biosimilars to market, the debate about animal research, olive leaf extract on trial, text mining in the biotech sector, outsourcing clinical trials in emerging markets and more.
Click to view.
Issue 46 | May 2016
In this issue: Getting a grip on the Zika virus, mining for medicines, Obama’s cancer moonshot, learning from Bial’s French trial disaster, digital innovation in pharmaceutical packaging and more.
Click to view.
Issue 45 | April 2016
In this issue: Israel’s pharma market, what Brexit would mean for clinical research in the UK, developments in obstetrics, the trouble with inhalable insulin, the FDA’s new support for innovation in manufacturing and more.
Click to view.
Issue 44 | March 2016
In this issue: Clinical trials in Russia, how understanding the microbiome could help with drug delivery, making the most of data analytics, the potential of wearable trackers in clinical trial data collection and more.
Click to view.
Issue 43 | February 2016
In this issue: A look inside China’s pharmaceutical market, GSK’s pipeline to 2020, tackling the world’s most pressing clinical needs, new digital tools for clinical trials, a new approach to predicting side effects and more.
Click to view.
Supplier Directory 2015
A directory of key product and service suppliers to the industry.
Click to view.
Issue 42 | January 2016
In this issue: Bridging the GP - big pharma divide, the year ahead in regulation, world-changing research into parasitic diseases, the first 3D printing method for adult stem cells, the ethics of marketing pharmaceuticals online, and more.
Click to view.
Issue 41 | December 2015
In this issue: regulation updates for EU-FMD and IDMP, why flibanserin remains controversial, why farm dust could be the key to preventing asthma, new efforts to reduce placebo use in clinical trials, and more.
Click to view.
Issue 40 | November 2015
In this issue: The industry’s quest for abuse-deterrent painkillers, progress of the US Drug Quality and Security Act, innovations in asthma treatment, the search for alternatives to antibiotics, and more.
Click to view.
Issue 39 | October 2015
In this issue: London’s proposed £10bn drug development ‘megafund’, why antibiotics innovation has stalled despite the growing AMR threat, new malaria research that could lead to a $1 cure, and more.
Click to view.
Issue 38 | September 2015
In this issue: South Africa's long road to domestic manufacturing, the 21st Century Cures Act divides opinion in the US, closing the talent gap in contract research, the growing market for unlicensed drugs and more.
Click to view.
Issue 37 | August 2015
In this issue: New findings on fake medicines, progress in predicting cancer, the rocky road ahead for biosimilars developers, a new wave of treatments for hearing loss, trends in packaging and more.
Click to view.
Issue 36 | July 2015
In this issue: A new gene therapy for lung cancer, a new approach to hepatitis B vaccines, tackling obesity with bioengineered bacteria, what Apple’s ResearchKit brings to clinical trials, big data solutions to pharma’s problems, European marketing self-regulation under fire and more.
Click to view.
Issue 35 | May 2015
In this issue: How pharmacogenomics is paving the way for personalised drug plans, new ideas for flu vaccine development, fighting antimicrobial resistance on all fronts, why a regulatory re-think is needed to unlock the potential of regenerative medicine and more.
Click to view.
Issue 34 | March 2015
In this issue: Unlocking unknown benefits of existing drugs, a new approach to stopping cancer spread, competition and opportunities in the HIV drugs market, building up business in Japan, striking the right balance with child-resistant drug packaging and more.
Click to view.
Issue 33 | January 2015
In this issue: Building on the success of dropping child cancer death rates in the UK, upcoming changes for 2015, the effects of mergers on innovation, rethinking the role of the placebo, neuropathic pain treatments in the pipeline, and more.
Click to view.
Supplier Directory 2014
A directory of key product and service suppliers to the industry.
Click to view.
Issue 32 | December 2014
In this issue: New combinations of existing cancer treatments show promising results, complying with new EU-FMD safety features, increasing time to market with new technologies, lymphoma treatments in the pipeline, tackling AMR with nanotechnology and more.
Click to view.
Issue 31 | October 2014
The clinical trials special issue: the economics of large-scale trials, new treatments for Type 2 Diabetes and obesity, the benefits of adaptive licensing for orphan drugs, data and trial management software and more.
Click to view.
Issue 30 | August 2014
In this issue: A new approach to Alzheimer’s clinical trials, India’s ambitions to jump from generics manufacturer to drug innovator, integrating real-life data into drug development, a new era for PAH treatment in the UK, self-expiring pharma packaging and more.
Click to view.
Issue 29 | June 2014
In this issue: Ireland's pharam market after the patent cliff, changes in life science investment, the drug pricing debate, statins in the spotlight, the medical potential of honey and more.
Click to view.
Issue 27 | February 2014
In this issue: Boosting clinical trial participation, the potential of bioprinting in regenerative medicine, progress in type 1 diabetes vaccines, controlling malaria and dengue fever outbreaks with open-source modelling, and more.
Click to view.
Issue 26 | December 2013
In this issue: We explore the potential of bioelectric medicine, find out how a landmark decision in the Supreme Court will affect DNA patent law, consider the ethics of advertising drugs directly to the consumer and more.
Click to view.
Issue 25 | October 2013
In this issue: How personalised medicine could revolutionise future medical care, recent breakthroughs in the battle against Malaria, how changes to GMP guidelines across Europe will affect CMOs and their customers, overcoming the challenges of managing cold chains in regions with weak infrastructures, a look at new anti-counterfeit regulations for manufacturing and distribution and more.
Click to view in Zmags.
Issue 24 | August 2013
In this issue: Could nano-robots change the game for targeted drug delivery? Plus: The cancer-killing avian virus, challenges in implementing the EC's Falsified Medicines Directive, Type 2 diabetes market insight, the placebo trend in the UK, the health implications of antibiotics in the food chain, new developments in drug delivery devices and more.
Click to view in Zmags.
Issue 23 | June 2013
In this issue: New opportunities for the generics market, the potential of plant molecular farming, a new generation of transdermal patches, how a new nerve targeting drug delivery system could revolutionise the treatment of intractable pain, the challenges of developing combination drugs, cold chain technology and more.
Click to view in Zmags.
Issue 22 | April 2013
In this issue: The EU's parallel drug trade dilemma, the controversy surrounding clinical data disclosure, a new subcutaneous drug delivery platform, the future of analgesic drug development, building an effective cold chain, Mexico's rise in the pharma market, growth opportunities for biopharma in Latin America and more.
Click to view in Zmags.
Issue 21 | March 2013
In this issue: New hope for preventative HIV vaccination, crowdfunding clinical research, effective cancer treatment with antibody-drug conjugates, the role of naïve t-cells in cancer and HIV treatment, continuous manufacturing, new inhalation technology and more.
Click to view in Zmags.
Issue 20 | December 2012
In this issue: The role of the supply chain in tackling drug shortages, getting emergency healthcare into Syria, cloud-based supply chain management, preventing medical cargo theft, the push for continuous temperature monitoring and more.
Click to view in Zmags.
Issue 19 | November 2012
In this issue: Why small biotech companies take the innovative edge in new drug development, a push for Alzheimer's research, the search for a more effective TB treatment, new schizophrenia discoveries and more.
Click to view in Zmags.
Issue 18 | October 2012
In this issue: From packaging technology to new legislation, industry and regulators are battling on all fronts against the spread of counterfeit medicines.
Click to view in Zmags.
Issue 17 | September 2012
In this issue: Are increasingly stringent regulations on manufacturing and ingredients the cause for the growing problem of drug shortages?
Click to view in Zmags.
Issue 16 | August 2012
In this issue: Clinical trials need better streamlined technology and industry-wide standards to become more efficient.
Click to view in Zmags.
Issue 15 | July 2012
In this issue: Programmable, self-propelled and powerful: how nano-devices could open up the door to a new era of highly targeted drug delivery.
Click to view in Zmags.
Issue 14 | June 2012
In this issue: How advanced computing technology will help Big Pharma to manage and streamline the growing amounts of ever more complex clinical data.
Click to view in Zmags.
Issue 13 | May 2012
In this issue: From advances in robotic research to new cures for addictions and life-threatening diseases, drug developers are opening up new frontiers.
Click to view in Zmags.
Issue 12 | April 2012
In this issue: Essential protection - pharmaceuticals place high demands on packaging, giving rise to ever more advanced packaging technologies to ensure the safety and usability of medicines.
Click to view in Zmags.
Issue 11 | March 2012
In this issue: Manufacturing and ingredients - we look at technological advances in the field of pharmaceutical manufacturing and APIs and explore some of the challenges faced by companies operating in the sector.
Click to view in Zmags.
Issue 10 | February 2012
In this issue: Trial & Success – we explore the best strategies and the latest technology that can hep to make clinical trials quicker, safer and more cost-efficient.
Click to view in Zmags.
Issue 9 | January 2012
In this issue: Advanced Delivery - from nanoscale targeting to controlled release breakthroughs, rapidly evolving delivery methods are making medicines more effective than ever.
Click to view in Zmags.
Issue 8 | December 2011
In this issue: Essential Networks - how the industry can secure supply chains while improving efficiencies in logistics.
Click to view in Zmags.
Issue 7 | November 2011
In this issue: Finding new cures - market shifts and emerging technologies are pushing drug development into a new era.
Click to view in Zmags.
Issue 6 | October 2011
In this issue: What's on the label - advanced packaging and labelling systems are essential in making medicines safer.
Click to view in Zmags.
Issue 5 | September 2011
In this issue: Life-saving precision: we look at trends in pharmaceutical manufacturing.
Click to view in Zmags.
Issue 4 | August 2011
In this issue: Combating counterfeits - how the industry can protect products, the supply chain and patients from the black market trade.
Click to view in Zmags.
Issue 3 | July 2011
In this issue: Better medicine - from needle free to nanotechnology, new drug delivery systems are set to revolutionise medical treatment.
Click to view in Zmags.
Issue 2 | June 2011
In this issue: The road to market - how pharma companies can meet the challenges of today's increasingly complex supply chains.
Click to view in Zmags.
